๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Enhancing antitumor by immunization with fusion of dendritic cells and engineered tumor cells

โœ Scribed by Zhang Weidong; Yang Hong; Zeng Hongtao

Publisher
Springer-Verlag
Year
2002
Tongue
Chinese
Weight
503 KB
Volume
22
Category
Article
ISSN
0510-9752

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Spleen-derived dendritic cells engineere
Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses
โœ Katsuyoshi Furumoto; Shigeki Arii; Seiji Yamasaki; Masaki Mizumoto; Akira Mori; ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 461 KB ๐Ÿ‘ 1 views

The major goal in cancer immunotherapy is the induction of tumor-specific T lymphocytes capable of killing tumor cells. As both dendritic cells (DCs) and interleukin-12 (IL-12) can play immunostimulatory roles in vivo, the use of a combination of these has become a promising approach. In the present